PEOPLE - Cytogen makes appointment:
This article was originally published in Clinica
Executive Summary
Dr Joseph Reiser has been appointed president and CEO of Cytogen, a US developer of site-specific cancer diagnostic imaging agents. Dr Reiser was previously with Schering's US pharmaceutical subsidiary, Berlex Laboratories.